Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of ACT-128800 in Patients With Relapsing-remitting Multiple Sclerosis

Clinical Investigative Site 1101, Vienna

Clinical Investigative Site 1905, Budapest

Clinical Investigative Site 1302, Sofia

Clinical Investigative Site 1204, Ottignies

Clinical Investigative Site 1301, Sofia

Clinical Investigative Site 1000, Westmead

Clinical Investigative Site 1900, Petofi

Clinical Investigative Site # 1001, Fitzroy

Clinical Investigative Site 1100, Sankt Pölten

Clinical Investigative Site 1102, Amstetten

Clinical Investigative Site 1901, Szentpeteri-Kapu

Clinical Investigative Site # 1205, Liège

Clinical Investigative Site 2203, Breda

Clinical Investigative Site 2201, Sittard-Geleen

Clinical Investigative Site 2202, Nijmegen

Clinical Investigative Site 1201, La Louvière

Clinical Investigative Site 1203, Sijsele-Damme

Clinical Investigative Site 1303, Varna

Clinical Investigative Site 1304, Varna

Clinical Investigative Site # 3128, New York

Clinical Investigative 1807, Berlin

Clinical Investigative Site 2501, Belgrade

Clinical Investigative Site 3120, Stony Brook

Clinical Investigative Site 3129, Latham

Clinical Investigative Site 3127, Schenectady

Clinical Investigative Site 1803, Berlin

Clinical Investigative Site 3302, Chernihiv

Clinical Investigative Site 2104, Genova

Clinical Investigative Site 2800, Stockholm

Clinical Investigative Site 2502, Niš

Clinical Investigative Site 3125, Philadelphia

Clinical Investigative Site 1602, Turku

Clinical Investigative Site # 2106, Milan

Clinical Investigative Site 2101, Gallarte

Clinical Investigative Site 3118, Baltimore

Clinical Investigative Site 3111, Richmond

Clinical Investigative Site 3119, Raleigh

Clinical Investigative Site 2702, Madrid

Clinical Investigative Site 2705, Madrid

Clinical Investigative Site 2701, Málaga

Clinical Investigative Site 1603, Tampere

Clinical Investigative Site 2503, Kragujevac

Clinical Invesigative Site 3116, Sarasota

Clinical Investigative Site 1701, Montpellier

Clinical Investigative Site 2102, Padua

Clinical Investigative site 1800, Düsseldorf

Clinical Investigative Site 2700, Seville

Clinical Investigative Site 2802, Gothenburg

Clinical Investigative Site 3130, Columbus

Clinical Investigator 3126, Akron

Clinical Investigative Site 1802, Essen

Clinical Investigative Site 3113, Cincinnati

Clinical Investigative Site 2704, Valencia

Clinical Investigative Site 3101, Indianapolis

Clinical Investigative Site 3303, Dnipropetrovsk

Clinical Investigative Site 2001, Tel Litwinsky

Clinical Investigative Site 2105, Siena

Clinical Investigator 3136, St Louis

Clinical Investigative Site 2003, Tel Aviv

Clinical Investigative Site 3304, Odesa

Clinical Investigative Site 3105, Kansas City

Clinical Investigative Site 3107, Lenexa

Clinical Investigative Site 1805, Homburg/Saar

Clinical Investigative Site 2002, Ẕerifin

Clinical Investigative Site 1501, Ostrava-Poruba

Clinical Investigative Site 2000, Ashkelon

Clinical Investigative Site 3132, Scottsdale

Clinical Investigative Site 3100, Tucson

Clinical Investigative Site 1804, Ulm

Clinical Investigative Site 2801, Umed

Clinical Investigative Site 3117, Stanford

Clinical Investigative Site # 1806, Bayreuth

Clinical Investigative Site 3115, Sacramento

Clinical Investigator 3104, Portland

Clinical Investigative Site 3102, Kirkland

Clinical Investigative Site # 3202, Moscow

Clinical Investigative Site # 3204, Saint Petersburg

Clinical Investigative Site 3201, Saint Petersburg

Clinical Investigative Site 3200, Saint Petersburg

Clinical Investigative Site 2402, Timișoara

Clinical Investigative Site # 3206, Pyatigorsk

Clinical Investigative Site 3209, Saratov

Clinical Investigative Site 2401, Cluj-Napoca

Clinical Investigative Site # 3201, Samara

Clinical Investigative Site 3208, Ufa

Clinical Investigative Site # 3203, Nizhny Novgorod

Clinical Investigative Site 3133, Worcester

Clinical Investigative Site # 3135, Newark

Clinical Investigative Site 3112, Burlington

Clinical Investigative Site 1401, Burbaby

Clinical Investigative Site # 1401, Burnaby

Clinical Investigative Site 1400, Ottawa

Clinical Investigative Site 1502, Brno

Clinical Investigative Site 1506, Jihlava

Clinical Investigative Site 1504, Olomouc

Clinical Investigative Site 1500, Prague

Clinical Investigative Site 1503, Teplice

Clinical Investigative Site 1600, Helsinki

Clinical Investigative Site 1601, Hyvinkää

Clinical Investigative Site # 1904, Budapest

Clinical Investigative Site 1908, Budapest

Clinical Investigative Site 1902, Győr

Clinical Investigative Site 2103, Roma

Clinical Investigative Site 2305, Katowice

Clinical Investigative Site 2303, Poznan

Clinical Investigative Site 2304, Warsaw

Clinical Investigative Site 2302, Wroclaw

Clinical Investigative Site 2400, Bucharest

Clinical Investigative Site 2706, Barcelona

Clinical Investigative Site 2901, Lugano

Clinical Investigative Site 2900, Sankt Gallen

Clinical Investigative Site 3300, Kyiv

Clinical Investigative Site 3003, Bristol

Clinical Investigative Site 3004, Devon

Clinical Investigative Site 3002, London